Joel Lee

Quantitative in vivo flux analysis reveals tumor and host lipogenic remodeling in KRAS-driven lung cancer

Upregulation of de novo lipogenesis is a hallmark of aggressive cancers, underscoring its potential as a therapeutic target. However, metabolic studies of lipogenesis during tumorigenesis in vivo remain limited relative to molecular investigations. Here, we quantitatively examine...